Kevin E. Weddington

Array ( [id] => 8312692 [patent_doc_number] => 20120189715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'COMPOSITIONS INCLUDING BETA-HYDROXY-BETA-METHYLBUTYRATE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/347978 [patent_app_country] => US [patent_app_date] => 2012-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20163 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13347978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8586997 [patent_doc_number] => 20130005818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'Glycogen or Polysaccharide Storage Disease Treatment Method' [patent_app_type] => utility [patent_app_number] => 13/343578 [patent_app_country] => US [patent_app_date] => 2012-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19506 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13343578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239262 [patent_doc_number] => 08604054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Triglyceride-lowering agent and hyperinsulinism-ameliorating agent' [patent_app_type] => utility [patent_app_number] => 13/334426 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3626 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13334426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8277431 [patent_doc_number] => 20120171302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING REDOX-SENSITIVE GTPASES' [patent_app_type] => utility [patent_app_number] => 13/332858 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 24468 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13332858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9198911 [patent_doc_number] => 20130338226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'INGENOLS FOR TREATING SEBORRHEIC KERATOSIS' [patent_app_type] => utility [patent_app_number] => 13/995177 [patent_app_country] => US [patent_app_date] => 2011-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2408 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9455292 [patent_doc_number] => 08716301 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation' [patent_app_type] => utility [patent_app_number] => 13/310264 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 30 [patent_no_of_words] => 20398 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13310264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056001 [patent_doc_number] => 20120077739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'METHODS FOR TREATING OBESITY EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/310097 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17875 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077739.pdf [firstpage_image] =>[orig_patent_app_number] => 13310097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9331099 [patent_doc_number] => 20140057881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'Composition for the Treatment of Skin Conditions' [patent_app_type] => utility [patent_app_number] => 13/995451 [patent_app_country] => US [patent_app_date] => 2011-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 3058 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9686636 [patent_doc_number] => 20140243401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'METHODS OF SCREENING COMPOUNDS THAT ARE CYTOTOXIC TO TUMOR CELLS AND METHODS OF TREATING TUMOR CELLS USING SUCH COMPOUND' [patent_app_type] => utility [patent_app_number] => 13/989731 [patent_app_country] => US [patent_app_date] => 2011-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 18196 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10031432 [patent_doc_number] => 09072732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Indication for use of niacin (nicotinic acid) for treatment and reversal of fatty liver disease' [patent_app_type] => utility [patent_app_number] => 13/988972 [patent_app_country] => US [patent_app_date] => 2011-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6284 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9149020 [patent_doc_number] => 20130303543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'PROTECTION OF RENAL TISSUES FROM ISCHEMIA THROUGH INHIBITION OF THE PROLIFERATIVE KINASES CDK4 AND CDK6' [patent_app_type] => utility [patent_app_number] => 13/988158 [patent_app_country] => US [patent_app_date] => 2011-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13145 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9149085 [patent_doc_number] => 20130303608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'STABLE AQUEOUS SUSPENSIONS OF DBNPA, THEIR PREPARATION AND USES THEREOF AS BIOCIDES' [patent_app_type] => utility [patent_app_number] => 13/884726 [patent_app_country] => US [patent_app_date] => 2011-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9885 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9183936 [patent_doc_number] => 08623868 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Processes of making and using pharmaceutical formulations of antineoplastic agents' [patent_app_type] => utility [patent_app_number] => 13/290251 [patent_app_country] => US [patent_app_date] => 2011-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5741 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13290251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754881 [patent_doc_number] => 20120027885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'NUTRITION CONTAINING FAT BLEND' [patent_app_type] => utility [patent_app_number] => 13/251399 [patent_app_country] => US [patent_app_date] => 2011-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3175 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027885.pdf [firstpage_image] =>[orig_patent_app_number] => 13251399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720897 [patent_doc_number] => 20120010232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'COMPOSITIONS FOR AFFECTING WEIGHT LOSS' [patent_app_type] => utility [patent_app_number] => 13/241023 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14691 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010232.pdf [firstpage_image] =>[orig_patent_app_number] => 13241023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9691324 [patent_doc_number] => 08821915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders' [patent_app_type] => utility [patent_app_number] => 13/200127 [patent_app_country] => US [patent_app_date] => 2011-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5690 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 378 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13200127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043369 [patent_doc_number] => 20120071424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'PHARMACEUTICAL COMPOSITION USED IN PROPHYLAXIS OR TREATMENT OF HYPERPROLIFERATIVE SKIN CONDITIONS AND MALIGNANT MELANOMAS COMPRISING PACHASTRISSAMINE AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 13/236080 [patent_app_country] => US [patent_app_date] => 2011-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8582 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071424.pdf [firstpage_image] =>[orig_patent_app_number] => 13236080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657306 [patent_doc_number] => 20110306575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'MEDICAL AND NUTRITIONAL APPLICATIONS OF HIGHLY REFINED CELLULOSE' [patent_app_type] => utility [patent_app_number] => 13/216793 [patent_app_country] => US [patent_app_date] => 2011-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24448 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306575.pdf [firstpage_image] =>[orig_patent_app_number] => 13216793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11414071 [patent_doc_number] => 09560875 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-07 [patent_title] => 'Treatment of animal carcasses' [patent_app_type] => utility [patent_app_number] => 13/216133 [patent_app_country] => US [patent_app_date] => 2011-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11891 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13216133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656536 [patent_doc_number] => 20110305805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'TREATMENT OF ANIMAL CARCASSES' [patent_app_type] => utility [patent_app_number] => 13/215124 [patent_app_country] => US [patent_app_date] => 2011-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11703 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305805.pdf [firstpage_image] =>[orig_patent_app_number] => 13215124 [rel_patent_id] =>[rel_patent_doc_number] =>)